A let-7 microRNA-binding site polymorphism in 3′-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuxi... von Zhang, W., Winder, T., Ning, Y., Pohl, A., Yang, D., Kahn, M., Lurje, G., LaBonte, M.J., Wilson, P.M., Gordon, M.A., Hu-Lieskovan, S., Mauro, D.J., Langer, C., Rowinsky, E.K., Lenz, H.-J.

Volltext

Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer von Baker, J B, Dutta, D, Watson, D, Maddala, T, Munneke, B M, Shak, S, Rowinsky, E K, Xu, L-A, Harbison, C T, Clark, E A, Mauro, D J, Khambata-Ford, S

Volltext

Heart rate variability in people with visual disability: Study Protocol von Moreno, Renaldo D., Abreu, Luiz C., Morais, Mauro J.D., Oliveira, Fabiano S., Bezerra, Italla M.P., Valenti, Vitor E., Sato, Monica A.

Volltext

Evaluation of the effects of aerobic training during hemodialysis on autonomic heart rate modulation in patients with chronic renal disease von Morais, Mauro J.D., Raimundo, Rodrigo D., Oliveira, Fabiano S., Abreu, Luiz C. de, Bezerra, Italla M.P., Silva, Romeu P.M., Rodrigues, Alliny S., Valenti, Vitor E., Pérez-Riera, Andrés R.

Volltext

A Human Nuclear Uracil DNA Glycosylase is the 37-kDa Subunit of Glyceraldehyde-3-Phosphate Dehydrogenase von Meyer-Siegler, Katherine, Mauro, David J., Seal, Gita, Wurzer, James, deRiel, Jon K., Sirover, Michael A.

Volltext

Mechanisms of excision of 5-fluorouracil by uracil DNA glycosylase in normal human cells von MAURO, D. J, DE RIEL, J. K, TALLARIDA, R. J, SIROVER, M. A

Volltext

A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer von Sclafani, Francesco, Kim, Tae Y, Cunningham, David, Kim, Tae W, Tabernero, Josep, Schmoll, Hans J, Roh, Jae K, Kim, Sun Y, Park, Young S, Guren, Tormod K, Hawkes, Eliza, Clarke, Steven J, Ferry, David, Frödin, Jan-Erik, Ayers, Mark, Nebozhyn, Michael, Peckitt, Clare, Loboda, Andrey, Mauro, David J, Watkins, David J

Volltext

Simultaneous determination of thiamine and riboflavin in enriched cereal based products by high-performance liquid chromatography using selective detection von Mauro, D.J., Wetzel, D.L.

Volltext

Comprehensive analysis of potential predictive biomarkers for insulin-like growth factor type-1 receptor (IGF-1R) targeted therapy in pancreatic cancer von Shroff, R. T., Javle, M. M., Li, D., Wolff, R. A., Mauro, D. J., Naumov, G., Nebozhyn, M., Zhang, T., Li, Y., Sathyanarayanan, S.

Volltext

Human epidermal growth factor receptor-2 (HER2) Ile655Val single nucleotide polymorphism (SNP) is associated with gender-specific outcome in patients with metastatic colorectal can... von Gerger, A., Bohanes, P. O., Yang, D., Winder, T., Ning, Y., Labonte, M. J., Mauro, D. J., Langer, C., Rowinsky, E. K., Lenz, H.

Volltext

Deformation and Cracking in Ge-Sb-Se Chalcogenide Glasses During Indentation von Varshneya, Arun K., Mauro, Daniel J., Rangarajan, Badri, Bowden, Bradley F.

Volltext

Use of germ-line polymorphisms in genes involved in the IGF pathway to predict efficacy of cetuximab independent of K-ras in mCRC patients (IMCL-0144) von Winder, T., Zhang, W., Yang, D., Ning, Y., Bohanes, P. O., Hu-Lieskovan, S., Mauro, D. J., Langer, C., Rowinsky, E. K., Lenz, H.

Volltext

A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuxi... von Zhang, W, Winder, T, Ning, Y, Pohl, A, Yang, D, Kahn, M, Lurje, G, LaBonte, M J, Wilson, P M, Gordon, M A, Hu-Lieskovan, S, Mauro, D J, Langer, C, Rowinsky, E K, Lenz, H-J

Volltext

Pityriasis rubra pilaris-like eruption associated with the multikinase inhibitor ponatinib von Jack, Alexander, MD, Mauro, Michael J., MD, Ehst, Benjamin D., MD, PhD

Volltext

Chronic Myeloid Leukemia: Is it Dusk or Dawn? von Mauro, Michael J., MD

Volltext

Evaluation of tumor gene expression and K-Ras mutations in FFPE tumor tissue as predictors of response to cetuximab in metastatic colorectal cancer von Baker, J. B., Dutta, D., Watson, D., Maddala, T., Shak, S., Rowinsky, E. K., Xu, L., Clark, E., Mauro, D. J., Khambata-Ford, S.

Volltext

Retrospective US database analysis of drug utilization patterns, health care resource use, and costs associated with adjuvant interferon alfa-2b therapy for treatment of malignant... von Hackshaw, Michelle D, Krishna, Arun, Mauro, David J

Volltext

Evaluating the impact of a switch to nilotinib on imatinib-related chronic low-grade adverse events in patients with CML-CP: the ENRICH study von Cortes, Jorge E., MD, Lipton, Jeffrey H., FRCPC, MD, PhD, Miller, Carole B., MD, Busque, Lambert, MD, Akard, Luke P., MD, Pinilla-Ibarz, Javier, MD, PhD, Keir, Christopher, MD, MS, Warsi, Ghulam, PhD, Lin, Felice P., PharmD, Mauro, Michael J., MD

Volltext

Management of Drug Toxicities in Chronic Myeloid Leukaemia von Mauro, Michael J., MD, Deininger, Michael W., MD, PhD

Volltext

Molecular Response in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated With Nilotinib: ENESTnext Update von Mauro, Michael J., MD, Dakhil, Shaker, MD, Cortes, Jorge E., MD, Rizzieri, David A., MD, Bonifacio, Gaetano, MD, Dautaj, Ilva, Warsi, Ghulam, Heinrich, Michael C., MD, Goldberg, Stuart L., MD, Catchatourian, Rosalind, MD, Kuriakose, Philip, MD, Radich, Jerald, MD

Volltext